ReviewNature reviews. Microbiology2026
Mosquito-based malaria control through genetic, microbial and immunological innovations.
Review in Nature reviews. Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria remains a major global health challenge, causing approximately 600,000 deaths annually despite decades of progress using insecticide-based and drug-based interventions. These core tools are increasingly compromised by widespread insecticide resistance in mosquitoes, drug resistance in parasites, adaptive vector behaviours and the lack of highly effective vaccines, together with logistical and sustainability constraints. Complementary strategies, including larval source management, environmental modification and novel insecticide formulations, also require sustained investment and strong community engagement. Novel Plasmodium transmission-blocking and Anopheles population-suppressing technologies, based on transgenic gene drives, natural and engineered microorganisms, and transmission-blocking vaccines and drugs, have the potential to redefine malaria control by providing parallel, sustainable, mosquito-targeted interventions. In this Review, we synthesize scientific advances underpinning these innovations, identify key knowledge gaps and discuss the science-based safeguards necessary for the responsible implementation of these malaria control strategies.
Identifiers
42869939What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.